A lot and stock price will go up as it did last year. Look for 3$ by end of June and some pull back before it takes of big.
the same hedge fund that you work for to manipulate and bring the price down for your bosses..
Just pray god every day that Neuvax should be successful in curing cancer. Money will automatically follow..
Sentiment: Strong Buy
James - I'm a long. DO you think some of the good data is already priced in and that the stock will only go so much even if the phase 3 data is good?
FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena, with a price target of $5.00, after the company announced its 758-patient PRESENT Phase III study with NeuVax to prevent recurrence in early-stage node-positive breast cancer reached the 70th qualifying disease-free survival (DFS) event.
Bernardino commented, “We believe the news confirms PRESENT is on track to reach an interim analysis readout of safety and study futility in 2Q16. We remind investors that 78% of subjects were disease free and alive at 24 months in the NeuVax Phase II trial (p = 0.04, HR = 0.00). We note that PRESENT has a high likelihood of low observer variability, as the events will be centrally adjudicated by an independent committee comprised of two oncologists and a radiologist with significant expertise in the conduct of clinical trials in breast cancer. Thus, we look for the interim PRESENT results to be positive and robust, significantly de-risking the final readout when the study reaches the 141 events in 2018. With the stock trading near the lows of its 52-week price range, we think the stock is trading at very attractive levels and would be buyers ahead of the interim analysis in 2Q16.”
Agreed and all good but the interim and final results of Neuvax should be good for Galena to succeed and the stock price to go up I hope it will be but only time will tell!
50% of my portfolio.. I'm betting heavily on this based on recent developments and hope God will help Galena deliver good results for curing women suffering from cancer.
It is good if you are a long and have more cash to buy cheaper. I'm all in! weak longs and day traders will be out soon which is good for the long run - good for true longs like us. Shorties won't have much shares available to cover later which is good for longs again. All set for a big ride until end of June. At the end, it all depends on how good the interim data will be. It is a gamble. Good luck!.
price will fluctuate over the next few months until the data is released end of June. manipulations will take the price down to 1$ again. as a long, i will add more and hope for good data and news end of this qtr. fingers crossed until then.
is heavily dependent on the data to be released at the end of June this year. I'm a long and looking to add more when the price drops again due to manipulation. Hope and pray god that the data should be so good!
nope..look for a pull back due to heavy shorting and manipulations..an opportunity to buy more if you are long. Unless the data to be released at end of june is good, the price will fluctuate around 1$